Alkermes to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Alkermes plc (Nasdaq: ALKS) will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 11:15 a.m. PST. CEO Richard Pops will host the presentation, which includes a question and answer session. The event can be accessed through the Investors tab on www.alkermes.com and will be archived for 14 days. Alkermes is a global biopharmaceutical company focusing on neuroscience and oncology, with various commercial products targeting alcohol and opioid dependence, schizophrenia, and bipolar I disorder.

DUBLIN, Dec. 28, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview and update at the 41^st Annual J.P. Morgan Healthcare Conference. The presentation will take place on Wednesday, Jan. 11, 2023 at 11:15 a.m. PST (2:15 p.m. EST/7:15 p.m. GMT), followed by a question and answer session. The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com. 

Contact: 
Jamie Bernard 
Investor Relations 
+1 781 873-2402

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301710669.html

SOURCE Alkermes plc

FAQ

When will Alkermes present at the J.P. Morgan Healthcare Conference?

Alkermes will present on January 11, 2023, at 11:15 a.m. PST.

Who will present on behalf of Alkermes at the conference?

CEO Richard Pops will provide the corporate overview at the conference.

How can I access the Alkermes presentation?

The live webcast will be available under the Investors tab on Alkermes' website.

Is there an archive available for the Alkermes presentation?

Yes, the presentation will be archived for 14 days after it airs.

What is Alkermes' focus in the biopharmaceutical sector?

Alkermes specializes in medications for alcohol and opioid dependence, schizophrenia, and bipolar I disorder.